Cargando…

Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?

OBJECTIVES: Anticoagulation for the prevention of cardio-embolism is most frequently indicated but largely underused in frail older patients with atrial fibrillation (AF). This study aimed at identifying characteristics associated with anticoagulation underuse. METHODS: A cross-sectional study of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Maes, Frédéric, Dalleur, Olivia, Henrard, Séverine, Wouters, Dominique, Scavée, Christophe, Spinewine, Anne, Boland, Benoit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105275/
https://www.ncbi.nlm.nih.gov/pubmed/25053883
http://dx.doi.org/10.2147/CIA.S62597
_version_ 1782327340516245504
author Maes, Frédéric
Dalleur, Olivia
Henrard, Séverine
Wouters, Dominique
Scavée, Christophe
Spinewine, Anne
Boland, Benoit
author_facet Maes, Frédéric
Dalleur, Olivia
Henrard, Séverine
Wouters, Dominique
Scavée, Christophe
Spinewine, Anne
Boland, Benoit
author_sort Maes, Frédéric
collection PubMed
description OBJECTIVES: Anticoagulation for the prevention of cardio-embolism is most frequently indicated but largely underused in frail older patients with atrial fibrillation (AF). This study aimed at identifying characteristics associated with anticoagulation underuse. METHODS: A cross-sectional study of consecutive geriatric patients aged ≥75 years, with AF and clear anticoagulation indication (CHADS(2) [Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack] ≥2) upon hospital admission. All patients benefited from a comprehensive geriatric assessment. Their risks of stroke and bleeding were predicted using CHADS(2) and HEMORR(2)HAGES (Hepatic or renal disease, Ethanol abuse, Malignancy, Older (age >75 years), Reduced platelet count or function, Rebleed risk, Hypertension (uncontrolled), Anemia, Genetic factors, Excessive fall risk, and Stroke) scores, respectively. RESULTS: Anticoagulation underuse was observed in 384 (50%) of 773 geriatric patients with AF (median age 85 years; female 57%, cognitive disorder 33%, nursing home 20%). No geriatric characteristic was found to be associated with anticoagulation underuse. Conversely, anticoagulation underuse was markedly increased in the patients treated with aspirin (odds ratio [OR] [95% confidence interval]: 5.3 [3.8; 7.5]). Other independent predictors of anticoagulation underuse were ethanol abuse (OR: 4.0 [1.4; 13.3]) and age ≥90 years (OR: 2.0 [1.2; 3.4]). Anticoagulation underuse was not inferior in patients with a lower bleeding risk and/or a higher stroke risk and underuse was surprisingly not inferior either in the AF patients who had previously had a stroke. CONCLUSION: Half of this geriatric population did not receive any anticoagulation despite a clear indication, regardless of their individual bleeding or stroke risks. Aspirin use is the main characteristic associated with anticoagulation underuse.
format Online
Article
Text
id pubmed-4105275
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41052752014-07-22 Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation? Maes, Frédéric Dalleur, Olivia Henrard, Séverine Wouters, Dominique Scavée, Christophe Spinewine, Anne Boland, Benoit Clin Interv Aging Original Research OBJECTIVES: Anticoagulation for the prevention of cardio-embolism is most frequently indicated but largely underused in frail older patients with atrial fibrillation (AF). This study aimed at identifying characteristics associated with anticoagulation underuse. METHODS: A cross-sectional study of consecutive geriatric patients aged ≥75 years, with AF and clear anticoagulation indication (CHADS(2) [Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack] ≥2) upon hospital admission. All patients benefited from a comprehensive geriatric assessment. Their risks of stroke and bleeding were predicted using CHADS(2) and HEMORR(2)HAGES (Hepatic or renal disease, Ethanol abuse, Malignancy, Older (age >75 years), Reduced platelet count or function, Rebleed risk, Hypertension (uncontrolled), Anemia, Genetic factors, Excessive fall risk, and Stroke) scores, respectively. RESULTS: Anticoagulation underuse was observed in 384 (50%) of 773 geriatric patients with AF (median age 85 years; female 57%, cognitive disorder 33%, nursing home 20%). No geriatric characteristic was found to be associated with anticoagulation underuse. Conversely, anticoagulation underuse was markedly increased in the patients treated with aspirin (odds ratio [OR] [95% confidence interval]: 5.3 [3.8; 7.5]). Other independent predictors of anticoagulation underuse were ethanol abuse (OR: 4.0 [1.4; 13.3]) and age ≥90 years (OR: 2.0 [1.2; 3.4]). Anticoagulation underuse was not inferior in patients with a lower bleeding risk and/or a higher stroke risk and underuse was surprisingly not inferior either in the AF patients who had previously had a stroke. CONCLUSION: Half of this geriatric population did not receive any anticoagulation despite a clear indication, regardless of their individual bleeding or stroke risks. Aspirin use is the main characteristic associated with anticoagulation underuse. Dove Medical Press 2014-07-15 /pmc/articles/PMC4105275/ /pubmed/25053883 http://dx.doi.org/10.2147/CIA.S62597 Text en © 2014 Maes et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Original Research
Maes, Frédéric
Dalleur, Olivia
Henrard, Séverine
Wouters, Dominique
Scavée, Christophe
Spinewine, Anne
Boland, Benoit
Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
title Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
title_full Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
title_fullStr Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
title_full_unstemmed Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
title_short Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
title_sort risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105275/
https://www.ncbi.nlm.nih.gov/pubmed/25053883
http://dx.doi.org/10.2147/CIA.S62597
work_keys_str_mv AT maesfrederic riskscoresandgeriatricprofilecantheyreallyhelpusinanticoagulationdecisionmakingamongolderpatientssufferingfromatrialfibrillation
AT dalleurolivia riskscoresandgeriatricprofilecantheyreallyhelpusinanticoagulationdecisionmakingamongolderpatientssufferingfromatrialfibrillation
AT henrardseverine riskscoresandgeriatricprofilecantheyreallyhelpusinanticoagulationdecisionmakingamongolderpatientssufferingfromatrialfibrillation
AT woutersdominique riskscoresandgeriatricprofilecantheyreallyhelpusinanticoagulationdecisionmakingamongolderpatientssufferingfromatrialfibrillation
AT scaveechristophe riskscoresandgeriatricprofilecantheyreallyhelpusinanticoagulationdecisionmakingamongolderpatientssufferingfromatrialfibrillation
AT spinewineanne riskscoresandgeriatricprofilecantheyreallyhelpusinanticoagulationdecisionmakingamongolderpatientssufferingfromatrialfibrillation
AT bolandbenoit riskscoresandgeriatricprofilecantheyreallyhelpusinanticoagulationdecisionmakingamongolderpatientssufferingfromatrialfibrillation